Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 19 May 2023 5 April 2024 5 April 2024 14880292 Prof Francesca Morgante iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14880292 2023-05-18 14880292 2024-04-05 14880292 2023-05-19 2024-04-05 14880292 frs-core:CurrentFinancialInstruments 2024-04-05 14880292 frs-bus:PrivateLimitedCompanyLtd 2023-05-19 2024-04-05 14880292 frs-bus:FilletedAccounts 2023-05-19 2024-04-05 14880292 frs-bus:Micro-entities 2023-05-19 2024-04-05 14880292 frs-bus:AuditExempt-NoAccountantsReport 2023-05-19 2024-04-05 14880292 frs-bus:Director1 2023-05-19 2024-04-05
Registered number: 14880292
Movement and Neuromodulation Limited
Unaudited Financial Statements
For the Period 19 May 2023 to 5 April 2024
Sharpe Medical Accounting Ltd
Balance Sheet
Registered number: 14880292
5 April 2024
£
Fixed assets 757
Current assets 29,235
Creditors: Amounts Falling Due Within One Year (9,922 )
NET CURRENT ASSETS 19,313
TOTAL ASSETS LESS CURRENT LIABILITIES 20,070
Accruals and deferred income (1,440 )
NET ASSETS 18,630
CAPITAL AND RESERVES 18,630

Notes

1. General Information
Movement and Neuromodulation Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14880292 . The registered office is C/O Sharpe Medical Accounting Limited, Normanby Gateway, Lysaghts Way, Scunthorpe, North Lincolnshire, DN15 9YG.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
Page 0
Page 1
For the period ending 5 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Prof Francesca Morgante
Director
31/07/2024